SPX3,652.55-2.49 -0.07%
DIA291.81-0.91 -0.31%
IXIC10,830.39+27.47 0.25%

SVB Leerink Initiates Coverage On Vir Biotechnology with Outperform Rating, Announces Price Target of $40

SVB Leerink analyst Roanna Ruiz initiates coverage on Vir Biotechnology (NASDAQ:VIR) with a Outperform rating and announces Price Target of $40.

Benzinga · 09/14/2022 06:54
SVB Leerink analyst Roanna Ruiz initiates coverage on Vir Biotechnology (NASDAQ:VIR) with a Outperform rating and announces Price Target of $40.